Mounjaro to Wegovy Conversion UK | Dose Chart & Prices

Clinically Proven UK Registered Pharmacy

Cheapest Mounjaro to Wegovy Conversion UK Price

Switch safely from Mounjaro to Wegovy with expert guidance at the cheapest UK price from £69.00, plus £20 off with code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

WEIGHTLOSSNEW £20 off for new customers

Treatment from £69.00

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check if you're eligible

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£99 £79.00

£19.75 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £99
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy Oral Pill
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy Oral Pill
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy Oral Pill
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy Oral Pill
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

Complete Mounjaro to Wegovy Dose Conversion & UK Pricing

Published on: June 03, 2026

Understanding mounjaro to wegovy conversion uk protocols is essential for patients considering a switch between these two leading weight loss medications. While both are injectable GLP-1 receptor agonists licensed by the MHRA, they work through different mechanisms and require careful dose equivalency assessment by a UK prescriber. At Cured Pharmacy, our clinical team provides personalised switching guidance with transparent pricing from £135.00 for Wegovy and from £135.00 for Mounjaro.

Understanding Mounjaro to Wegovy Conversion UK Protocols

Switching from Mounjaro (tirzepatide) to Wegovy (semaglutide) requires clinical consideration because these medications act through different receptor pathways. Mounjaro is a dual GIP/GLP-1 receptor agonist, whilst Wegovy targets only the GLP-1 receptor [1]. This fundamental difference means there is no direct milligram-to-milligram dose equivalency between the two treatments.

UK prescribers typically assess your current Mounjaro dose, treatment duration, weight loss progress, and tolerance profile before determining an appropriate Wegovy starting dose. Most patients transitioning from Mounjaro restart Wegovy at the standard 0.25mg weekly dose and follow the manufacturer's escalation schedule, rather than jumping directly to a higher maintenance dose [2]. This approach minimises gastrointestinal side effects and allows your body to adjust to the new medication mechanism.

Clinical evidence suggests that patients established on higher Mounjaro doses (10mg or 15mg weekly) may experience continued weight loss on Wegovy's maximum 2.4mg dose, though the magnitude of effect may differ. The STEP 1 trial demonstrated an average 14.9% body weight reduction with semaglutide 2.4mg over 68 weeks, whilst SURPASS-1 showed tirzepatide 15mg produced 21% average reduction over 40 weeks [1][3]. Your UK prescriber will monitor your response during the transition period and adjust accordingly.

Mounjaro Wegovy Dose Equivalent: Clinical Comparison

Establishing a mounjaro wegovy dose equivalent is not straightforward due to their differing mechanisms of action. Tirzepatide's dual receptor activity produces greater weight loss outcomes in clinical trials compared to semaglutide, meaning a lower Mounjaro dose may produce similar effects to a higher Wegovy dose [1]. However, individual patient response varies significantly, making personalised assessment essential.

Clinical studies provide some guidance on comparative efficacy. Research comparing tirzepatide 10mg weekly to semaglutide 2.4mg weekly showed tirzepatide produced approximately 5-7% greater total body weight reduction over similar timeframes [4]. This suggests patients on Mounjaro 10mg transitioning to Wegovy's maximum 2.4mg dose should expect continued weight loss, though potentially at a reduced rate compared to their Mounjaro trajectory.

For patients on Mounjaro maintenance doses of 5mg, 10mg, or 15mg weekly, UK prescribers typically recommend transitioning to Wegovy using the standard dose escalation schedule starting at 0.25mg. This cautious approach, endorsed by clinical guidelines, allows proper tolerance assessment and reduces the risk of significant gastrointestinal adverse events during the medication switch [2].

Practical Dose Transition Guidelines

When switching from mounjaro to wegovy uk protocols, timing matters. Most UK prescribers recommend administering your first Wegovy dose one week after your last Mounjaro injection, maintaining the weekly injection schedule without overlap. This prevents excessive GLP-1 receptor stimulation whilst avoiding gaps in treatment that might trigger increased appetite or blood sugar fluctuations. Your prescriber may adjust this timing based on your individual tolerance and any side effects experienced on Mounjaro.

Switching From Mounjaro to Wegovy UK: Cost Considerations

Cost is a primary factor driving many UK patients to consider switching from mounjaro to wegovy uk options. At Cured Pharmacy, Wegovy starts from £124.99 compared to Mounjaro from £124.99 representing significant monthly savings for patients paying privately. Over a 12-month treatment course, this price difference can amount to substantial savings whilst maintaining effective weight management support.

Beyond the medication cost itself, UK patients should consider the complete treatment investment including ongoing prescriber reviews, potential dose adjustments, and monitoring requirements. Both medications require regular clinical follow-up to assess efficacy, tolerance, and appropriateness for continued use. At Cured Pharmacy, all prescription treatments include free online consultations with UK-registered prescribers, ensuring you receive comprehensive clinical support regardless of which medication you choose.

Some patients find that despite the higher cost, Mounjaro's dual-action mechanism produces superior weight loss outcomes that justify the additional expense. Others achieve their weight management goals effectively on Wegovy at the lower price point. Your UK prescriber will help you weigh these clinical and financial considerations to determine the most appropriate treatment for your individual circumstances and budget.

Long-Term Treatment Planning

Weight loss medications work best as part of a comprehensive lifestyle programme including dietary modifications and increased physical activity. Whether you continue with Mounjaro or switch to Wegovy, sustainable results require ongoing commitment to behaviour change. UK clinical guidelines recommend regular review appointments every 3-6 months to assess treatment effectiveness, with discontinuation considered if you haven't achieved at least 5% body weight reduction after 6 months at the maximum tolerated dose [5].

Medication Active Ingredient Mechanism Starting Dose Maximum Dose Price at Cured Pharmacy
Mounjaro Tirzepatide Dual GIP/GLP-1 agonist 2.5mg weekly 15mg weekly From £124.99
Wegovy Semaglutide GLP-1 agonist 0.25mg weekly 2.4mg weekly From £69.00
Saxenda Liraglutide GLP-1 agonist 0.6mg daily 3mg daily From £68.00

Tirzepatide to Semaglutide Conversion: What to Expect

Understanding the tirzepatide to semaglutide conversion process helps set realistic expectations during your medication transition. Most patients experience a continuation of weight loss when switching from Mounjaro to Wegovy, though the rate of loss may change. Clinical data suggests semaglutide produces steady, sustained weight reduction averaging 1-2% body weight per month during the dose escalation phase [3].

Common experiences during the conversion period include temporary changes in appetite regulation, as your body adjusts to the single-pathway GLP-1 mechanism after dual GIP/GLP-1 stimulation. Some patients report increased hunger during the first 2-4 weeks on lower Wegovy doses compared to their previous Mounjaro maintenance dose. This typically normalises as you progress through the Wegovy dose escalation schedule towards the 2.4mg maintenance dose.

Gastrointestinal side effects represent the most frequently reported concern during medication switches. Nausea, altered bowel habits, and reduced appetite affect approximately 40-50% of patients starting semaglutide, though these effects are generally mild to moderate and diminish over time [2][3]. Starting Wegovy at the lowest 0.25mg dose and following the gradual escalation protocol significantly reduces the severity and duration of these side effects compared to starting at higher doses.

Mounjaro vs Wegovy Dosing Chart: Clinical Escalation Schedules

Both Mounjaro and Wegovy follow structured dose escalation schedules designed to optimise efficacy whilst minimising side effects. Mounjaro starts at 2.5mg weekly for four weeks, then increases to 5mg, with further escalations to 7.5mg, 10mg, 12.5mg, and a maximum of 15mg weekly based on individual response and tolerance [1]. Each dose increase occurs at minimum four-week intervals, allowing your body to adapt to the medication's effects.

Wegovy's escalation schedule begins at 0.25mg weekly for four weeks, progressing to 0.5mg, 1mg, 1.7mg, and finally the maintenance dose of 2.4mg weekly. This more gradual initial escalation (0.25mg vs 2.5mg starting doses) reflects semaglutide's potent GLP-1 receptor activity and helps reduce the incidence of gastrointestinal adverse events [2]. The entire escalation to maximum dose takes approximately 16-20 weeks for both medications.

UK prescribers may adjust these standard schedules based on your individual tolerance. If you experience significant side effects at any dose level, your prescriber might recommend staying at your current dose for an additional four weeks before attempting the next increase, or selecting a lower maintenance dose that balances efficacy with tolerability. Clinical trials show that even submaximal doses of both medications produce clinically meaningful weight loss in most patients [1][3].

Monitoring During Dose Transitions

Regular monitoring during your mounjaro to wegovy conversion uk journey ensures optimal outcomes and early identification of any concerns. Your UK prescriber will typically schedule follow-up consultations at 4-week intervals during the Wegovy escalation phase, assessing weight loss progress, side effect profile, and treatment adherence. Blood pressure, heart rate, and in some cases blood glucose monitoring may be recommended, particularly for patients with pre-existing cardiovascular or metabolic conditions.

Wegovy After Mounjaro UK: Patient Outcomes and Expectations

Real-world evidence from UK patients using wegovy after mounjaro uk transitions shows varied but generally positive outcomes. Many patients report continued weight loss or successful weight maintenance on Wegovy following their Mounjaro course, particularly when combined with sustained lifestyle modifications. The key to success lies in maintaining realistic expectations and understanding that weight loss trajectories differ between the two medications.

Clinical data indicates that patients who achieved significant weight loss on Mounjaro (15% or more total body weight reduction) typically maintain most of this loss when transitioning to Wegovy, with some experiencing additional modest reductions. Those switching primarily for cost reasons rather than clinical necessity generally report satisfaction with Wegovy's efficacy, particularly once reaching the 2.4mg maintenance dose [3][4].

Long-term treatment adherence remains the strongest predictor of sustained weight management success regardless of which medication you use. UK guidelines emphasise that both Mounjaro and Wegovy work most effectively as part of a comprehensive weight management programme including dietary counselling, increased physical activity, and behavioural support. At Cured Pharmacy, our UK clinical team provides ongoing guidance to support your long-term success, whether you continue with Mounjaro or switch to Wegovy based on your individual needs and circumstances.

Scientific References

  1. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
  2. Novo Nordisk. (2023). Wegovy (semaglutide) Summary of Product Characteristics. Electronic Medicines Compendium. https://www.medicines.org.uk/emc/product/13799 [accessed 13 August 2026]
  3. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
  4. Frías, J. P., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519 [accessed 13 August 2026]
  5. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity. NICE Technology Appraisal Guidance [TA875]. https://www.nice.org.uk/guidance/ta875 [accessed 13 August 2026]
  6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
  7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
  8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication or switching between weight loss treatments. Individual results may vary, and weight loss outcomes depend on multiple factors including adherence to treatment, lifestyle modifications, and metabolic response.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

Can I switch directly from Mounjaro 10mg to Wegovy 2.4mg?
No. UK prescribers recommend starting Wegovy at the 0.25mg dose and following the standard escalation schedule, even if you're on a high Mounjaro dose. This gradual approach minimises side effects and allows proper tolerance assessment during the mounjaro to wegovy conversion uk process.
How long after stopping Mounjaro can I start Wegovy?
Most UK prescribers recommend starting Wegovy one week after your last Mounjaro injection, maintaining your weekly injection schedule. Your prescriber may adjust this timing based on your individual tolerance and any side effects experienced.
Will I regain weight when switching from Mounjaro to Wegovy UK?
Most patients maintain their weight loss or continue losing weight when switching from mounjaro to wegovy uk, particularly once reaching the 2.4mg maintenance dose. Individual results vary based on lifestyle factors, adherence, and metabolic response.
What is the mounjaro wegovy dose equivalent for weight loss?
There is no direct milligram-to-milligram mounjaro wegovy dose equivalent due to different mechanisms of action. Clinical trials suggest Mounjaro 10mg produces approximately 5-7% greater weight loss than Wegovy 2.4mg, though individual responses vary significantly.
Is Wegovy as effective as Mounjaro for weight loss?
Both medications produce clinically significant weight loss. Mounjaro demonstrated average 21% body weight reduction at the 15mg dose in SURPASS trials, whilst Wegovy showed 14.9% reduction at 2.4mg in STEP trials. Your UK prescriber will recommend the most appropriate option for your individual circumstances.
Can I switch back to Mounjaro if Wegovy doesn't work?
Yes. If you don't achieve adequate weight loss on Wegovy's maximum dose, your UK prescriber may recommend switching back to Mounjaro. All medication changes require clinical assessment and prescriber approval based on your individual response and medical history.
Do I need a new prescription when switching from Mounjaro to Wegovy?
Yes. Mounjaro and Wegovy are different prescription medications requiring separate prescriptions from a UK-registered prescriber. At Cured Pharmacy, our clinical team will conduct a new assessment before prescribing Wegovy, reviewing your Mounjaro treatment history and current health status.
What are the side effects when converting tirzepatide to semaglutide?
Common side effects during tirzepatide to semaglutide conversion include nausea, altered bowel habits, and temporary changes in appetite. These effects are typically mild to moderate and diminish as you progress through the Wegovy dose escalation schedule.
What is the equivalent Wegovy dose when converting from Mounjaro in the UK?
When converting from Mounjaro to Wegovy in the UK, most prescribers recommend starting at Wegovy 0.5mg or 1mg if you were on Mounjaro 2.5mg to 5mg, depending on tolerance. Cured Pharmacy's UK-registered clinicians will assess your current Mounjaro dose and medical history to determine the safest Wegovy starting point for your conversion.
Is Wegovy cheaper than Mounjaro when switching in the UK?
Yes, Wegovy starting doses are typically cheaper than Mounjaro — Wegovy 0.25mg costs £69.00 versus Mounjaro 2.5mg at £124.99. If you're converting from Mounjaro to Wegovy at Cured Pharmacy, you can save £20 off your first Wegovy order with code Weightlossnew, making it even more affordable.
How long does Mounjaro to Wegovy conversion take in the UK?
The Mounjaro to Wegovy conversion process at Cured Pharmacy typically takes 24-48 hours for prescriber review and approval. Once approved, your Wegovy prescription is dispatched with next-day delivery, allowing you to transition smoothly without interrupting your weight loss treatment.
Can I switch from Mounjaro to Wegovy if I'm mid-dose escalation?
Yes, you can switch from Mounjaro to Wegovy mid-escalation, but your prescriber will carefully match your current Mounjaro dose to an appropriate Wegovy starting dose. Cured Pharmacy's UK clinicians evaluate your tolerance and weight loss progress to ensure a safe, effective conversion without restarting from the lowest dose unnecessarily.
Will I lose progress converting from Mounjaro to Wegovy in the UK?
No, converting from Mounjaro to Wegovy should not cause you to lose weight loss progress, as both medications work on similar pathways (GLP-1 receptors). Cured Pharmacy's prescribers ensure your Wegovy dose is appropriately matched to your Mounjaro regimen, maintaining appetite suppression and metabolic benefits throughout the transition.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 13 August 2026

Last updated on 13 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 13 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (13 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.